Member Announcements 2012

 

December 28, 2012

Verisante Issues Stock Options

 

December 27, 2012

Functional Technologies Reports 2012 Financial Results

 

December 21, 2012

Allon cuts staff and administrative costs

 

December 21, 2012

EnWave Grants Stock Options

 

December 21, 2012

Unveiling the Verification Plan in Medical Device Design

 

December 20, 2012

Verisante Provides Operational Update

 

December 19, 2012

OncoGenex Announces Initiation of Randomized Phase 2 “PACIFIC” Study of OGX-427 in combination with Zytiga ® in Men with Metastatic Castrate-Resistant Prostate Cancer

 

December 19, 2012

First Mobile Application for Bioanalytical Assays in the Industry

 

December 19, 2012

The Next Big Thing: UBC researchers predict game-changers that could rock our world

 

December 18, 2012

UBC scientists part of three PhysicsWorld’s top 10 breakthroughs

 

December 17, 2012

Dr. Susan Stansfield, Joins inVentiv Health as Executive Vice President, Clinical Operations

 

December 17, 2012

Sirona Biochem Announces New Grant of Stock Options

 

December 14, 2012

A $2.5 Million Gift to the BC Cancer Foundation Provides Cancer Researchers with Top-of-the-Line Tools

 

December 14, 2012

New Physiotherapy Teaching Lab Opens in the North

 

December 14, 2012

New Physiotherapy Teaching Lab Opens in the North

 

December 13, 2012

Brining Our Tests to Market

 

December 12, 2012

UBC leads national study on HPV vaccine

 

December 11, 2012

Cardiome Reaches Agreement With Merck To Retire Debt And Close Line Of Credit

 

December 11, 2012

Teva and Xenon Announce Teva’s World Wide License of Xenon’s Pain Drug XEN402

 

December 11, 2012

Hug – Medical Tubing Manager

 

December 6, 2012

QLT Announces Reduction In Force

 

December 6, 2012

Earthquake opportunity

 

December 6, 2012

Medical tourists embrace surgery

 

December 6, 2012

Research data repository coming

 

December 6, 2012

Winston awarded Diamond Jubilee Medal

 

December 5, 2012

The United States, New Zealand & Mexico Issue Patent for New Allon Platform

 

December 5, 2012

Novadaq Announces First PINPOINT Purchase Order

 

December 5, 2012

Nanomedicines and Drug Delivery Group celebrates one year anniversary

 

December 5, 2012

Sorin Group Announces First Paradymâ„¢ Rf Implant And Subsequent First Smartviewâ„¢ Remote Monitoring Activated Patient In North America

 

December 5, 2012

Dean of Nursing Named One of Canada’s Most Powerful Women in 2012 Awards

 

December 5, 2012

Creating new opportunities for international medical graduates

 

December 4, 2012

Sirona Biochem’s Inducer Performs Better than Industry Standard IPTG in Independent McMaster University Study

 

December 4, 2012

Sorin Group Receives Pmda Approval And Announces Commercial Launch Of The Mitroflow ® Aortic Pericardial Heart Valve In Japan

 

December 4, 2012

Another culprit for obesity: Too much insulin

 

December 4, 2012

Examiners tend to grade relative to work already seen: UBC research

 

December 3, 2012

BC Cancer Agency Announces Recipient of Provincial Community Cancer Care Award

 

December 3, 2012

Alzheimer’s researcher reveals a protein’s dual destructiveness and therapeutic potential

December 1, 2012

Controlled trial with Caphosol published in Supportive Care in Cancer

 

November 30, 2012

iCo Therapeutics Announces Third Quarter 2012 Financial Results

 

November 29, 2012

Kinexus Announces the Launch of a New Antibody Microarray Kit

 

November 29, 2012

iCo Therapeutics Announces Third Quarter 2012 Financial Results

 

November 29, 2012

Qu Biologics welcomes Dr. David W. Mullins to our Scientific Advisory Board

 

November 29, 2012

Inviting customer complaints can kill business: UBC research

 

November 29, 2012

Allon selected as Top 10 partnering prospect by CNS experts

 

November 29, 2012

Tekmira Acquires Worldwide License to Novel RNAi Technology

 

November 29, 2012

Sirona Biochem’s Cosmetic Skin Lighteners More Stable Than Leading Compound, According to New Study

 

November 29, 2012

Qu Biologics welcomes Dr. David W. Mullins to our Scientific Advisory Board

 

November 29, 2012

Inviting customer complaints can kill business: UBC research

 

November 28, 2012

K’Prime Technologies Inc Welcomes Jocelyn Madeira as new Genomics Account Manager

 

November 27, 2012

HTG Molecular Diagnostics and PROOF Centre Partner to Commercialize COPD Prognostic Test

 

November 26, 2012

Neovasc Inc. Reports Financial Results For Third Quarter Of 2012

 

November 26, 2012

Barely surviving to thriving – a remarkable 27-year journey with HIV

 

November 26, 2012

Sorin Group Invests In Highlife, A Development-Stage Company Focused On Percutaneous Mitral Valve Replacement

 

November 26, 2012

UBC inventor of self-propelled coagulant wins grant from Grand Challenges Canada

 

November 23, 2012

BC Cancer Foundation’s Jingle Mingle Poised to Advance Patient Navigation Research on Vancouver Island

 

November 22, 2012

Verisante Featured on Business Television (BTV)

 

November 22, 2012

Sirona Biochem’s Second Skin Lightening Compound Shows Superiority Over Industry Standard in Study

 

November 22, 2012

New VPR site: ‘Open doors, Open knowledge’

 

November 22, 2012

UBC celebrates Royal Society inductees

 

November 22, 2012

UBC Researcher and CDRD Collaborator Dr. Santiago Ramón-García Publishes on Potential New Therapy for TB

 

November 20, 2012

BC Cancer Foundation named Top Pick in Charity Intelligence Canada’s 2012 Report

 

November 20, 2012

Verisante Aura Named Finalist for 2013 SPIE Prism Award

 

November 20, 2012

Sirona Biochem’s Subsidiary TFChem Winner of Acclaimed Innovation Award in France

 

November 20, 2012

Adherence to HIV treatment significantly increases survival: UBC study

 

November 19, 2012

Biolux Research Announces Sponsorship Of Inaugural Rapid Orthodontics Symposium At Aeedc 2013 In Dubai, UAE

 

November 19, 2012

Earl W. Davie Symposium Draws Record Attendance — Including A Nobel Laureate

 

November 19, 2012

UBC professor and CDRD co-founder wins Canada’s top pharmaceutical research award

 

November 16, 2012

EnWave’s 3rd Tier 1 Collaborator Enters Into Market Evaluation Following Successful R&D Phase

 

November 16, 2012

UBC’s commitment to science education underlined by $75M facility

 

November 16, 2012

Note Change Of Address And Phone For CDRD And CDRD Ventures Inc.

 

November 16, 2012

In the News: Prof Davidoff talks about the danger of rising Canadian personal debt

 

November 15, 2012

Collaboration Marks First National Partnership for Rx&D and BioTalent Canada

 

November 15, 2012

Sirona Biochem’s Skin Lightener Compound Seven Times More Effective Than Popular Commercial Lightener in Study

 

November 14, 2012

Chris Halyk Appointed Chair, Rx&D Board of Directors

 

November 14, 2012

Rx&D announces the creation of 3 scholarships

 

November 14, 2012

SFU research goes virtual

 

November 14, 2012

Cardiome Reports Third Quarter Results

 

November 14, 2012

Response Biomedical Corp. Announces Third Quarter 2012 Financial Results

 

November 14, 2012

Sauder’s Ch’nook hosts inaugural Maori MBA study tour

 

November 14, 2012

BC Cancer Agency offers tips to prevent cancer and avoid “winter hibernation”

 

November 14, 2012

Blood Marker Can Help Diagnose Rheumatoid Arthritis; New Data at the 2012 Annual Meeting of the American College of Rheumatology

 

November 14, 2012

Transporting hypothermia victims to advanced heart and lung care facilities “worth the trip”

 

November 14, 2012

BC Cancer Foundation 2012 Discovery Luncheon advances PREDICT project in the Southern Interior with $60,000

 

November 14, 2012

UNBC Professor the First Northern Recipient of a MSFHR/NCCAH Scholar Award

 

November 13, 2012

Patient treatment completed in pivotal trial evaluating Allons davunetide

 

November 13, 2012

Abbott, Gilead reveal topline results for oral hep C drugs

 

November 13, 2012

Sirona Biochem Announces Stock Options Exercise Price Revision

 

November 13, 2012

Tekmira Provides Corporate Update and Announces Third Quarter 2012 Results

 

November 13, 2012

UNBC Research Sheds Light on Notorious Mountain Pine Beetle Ability

 

November 13, 2012

Canadian Premature Babies Foundation launches

 

November 12, 2012

Tekmira and Alnylam Restructure Relationship and Settle All Litigation

 

November 12, 2012

Sorin Group Announces The Acquisition Of Neurotech, A Development-Stage Company Focused On Neurostimulation

 

November 10, 2012

Boehringer Ingelheim’s interferon-free all-oral hepatitis C treatment+ shows up to 85% viral cure in Phase IIb study including patients with advanced liver disease

 

November 9, 2012

Mobilizing Knowledge: ED pilot project is improving patient care and protecting health resources

 

November 9, 2012

Faculty Of Medicine Celebrates 10 Years Of Recruiting And Supporting Aboriginal Students

 

November 8, 2012

Verisante Technology, Inc. Issues Operational Update

 

November 8, 2012

Allon’s Target Price Increased in Recent Canaccord Genuity Report

 

November 8, 2012

RELY-ABLE ®: Unprecedented long-term data support safety profile and sustained efficacy of PRADAX ® for stroke prevention in AF

 

November 8, 2012

Scientists find more genome variants

 

November 8, 2012

Funding advances health discoveries

 

November 8, 2012

Birds evolution accelerating, study says

 

November 7, 2012

Response Biomedical Corp. Announces the CE Mark of D-dimer Assay for the EU Market

 

November 7, 2012

ICORD’s annual report is now available

 

November 7, 2012

Pritchard Family donates $200,000 to BC Cancer Foundation to boost research

 

November 7, 2012

QLT Announces Third Quarter 2012 Results

 

November 7, 2012

RepliCel Completes First Pre-Filing Review with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process

 

November 6, 2012

Top Canadian, Indian institutions form $30M partnership to improve water and infrastructure safety, eradicate diseases

 

November 6, 2012

OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 “SYNERGY” Study

 

November 5, 2012

Living Through Pain – A young man’s story of perseverance

 

November 5, 2012

B.C.’s Environment Minister at SFU Vancouver

 

November 5, 2012

Allon Therapeutics releases Q3 operating results and provides corporate update

 

November 5, 2012

The Centre for Drug Research and Development Announces Appointment of New Directors

 

November 1, 2012

Researchers and clinicians receive awards at National Spinal Cord Injury Conference

 

November 1, 2012

Neovasc Inc. finalizes us $4.6 million agreement giving lemaitre vascular rights to in-house manufacture of xenosure ® surgical patch

 

October 31, 2012

Cohen Commission Media Advisory

 

October 31, 2012

The Histological Analysis of Implantable Medical Devices

 

October 31, 2012

Arthritis Takes a Toll on Working Population

 

October 31, 2012

Bird tree tells new tale of evolution

 

October 31, 2012

Sorin Group Announce 2012 Third Quarter Results

 

October 31, 2012

StartUp Weekend Victoria 2012

 

October 30, 2012

Three Immunologists join Network Immunology Inc.

 

October 30, 2012

EnWave Completes Acquisition of 86.5% Controlling Interest in Hans Binder Maschinenbau GmbH

 

October 30, 2012

OncoGenex to Webcast Discussion of Third Quarter 2012 Financial Results on Thursday, November 8, 2012

 

October 30, 2012

UBC spin-off company ready to launch phone-based pulse oximeter

 

October 29, 2012

Qu Biologics welcomes Dr. David W. Mullins to our Scientific Advisory Board

 

October 29, 2012

Grad develops bone tissue replacement technique

 

October 29, 2012

NASDAQ Approves Cardiome’s Request to Transfer its Listing to the NASDAQ Capital Market

 

October 29, 2012

Premier Clark opens BC Cancer Agency Centre for the North

 

October 26, 2012

QLT Shows Positive Efficiancy Trends Frin Data in Plug Combinations in Phase II Studies for Glaucoma Using Latanoprost Punctal Delivery System

 

October 25, 2012

Arazy Group Launches Unique, Cloud-based System to Accelerate Multi-National Registration of Medical Devices

 

October 25, 2012

Scientists deepen genetic understanding of MS

 

October 25, 2012

Allon on target for pivotal PSP data by year end

 

October 25, 2012

Tracking environmental causes of good and bad health

 

October 25, 2012

Tying our fate to molecular markings

 

October 25, 2012

Universities seek 11,000 more spaces

 

October 23, 2012

Neovasc’s Tiaraâ„¢ transcatheter mitral valve selected as a “best” new device concept at TCT 2012 Scientific Symposium

 

October 23, 2012

Summer babies less likely to be CEOs: UBC research

 

October 22, 2012

Cervical cancer survivor urges women to get regular Pap test

 

October 22, 2012

New reports highlight health, economic benefits of new medicines. Economic Impact of Canada’s innovative pharmaceutical sector exceeds $3-billion

 

October 22, 2012

Cauley Interviewed by the TV Show BioMed Reports

 

October 22, 2012

Qu Biologics’ first Japanese patent has been allowed

 

October 19, 2012

iCo Therapeutics Engages HT Capital for Investor Communication Services

 

October 19, 2012

Cholera discovery could revolutionize antibiotic delivery

 

October 19, 2012

Terry Fox Foundation supports UBC research into aggressive leukemia

 

October 19, 2012

A new leader for B.C. heart research and care

 

October 18, 2012

Northern cancer survivorship care study already having positive effect

 

October 18, 2012

EnWave Acquires 86.5% Controlling Interest in Hans Binder Maschinenbau GmbH and Secures Global Rights to the MIVAPâ„¢ Technology

 

October 18, 2012

International tendonopathy symposium -improving patient care

 

October 18, 2012

Genes and immune system shaped by childhood poverty, stress

 

October 18, 2012

Some MS patients experience “natural” improvements in disability: UBC-VCH research

 

October 18, 2012

Sirona Biochem Names Nigel Terrett as Strategic Advisor

 

October 18, 2012

Neovasc Announces Upcoming Presentations at TCT 2012 Scientific Symposium

 

October 17, 2012

Fish controversy nets Sterling prize

 

October 17, 2012

Qu Biologics is honoured to welcome Dr. Bradley Thompson to our Board of Directors

 

October 17, 2012

New research: ‘Natural’ improvements could open doors for new MS treatments

 

October 17, 2012

CDRD Seminar Featuring Dr. Marlene Haffner, Former Director of FDA Office of Orphan Products Development Draws Full House — Download Presentation Here

 

October 16, 2012

Wax-it Histology Services Receives GLP Accreditation

 

October 16, 2012

Collaborations to improve health care

 

October 16, 2012

Maxxam President & CEO Jon Hantho a Winner at Ernst & Young Entrepreneur Of The Year ® Awards

 

October 16, 2012

Aubrey J. Tingle Prize presented to Dr. Bruce McManus

 

October 16, 2012

NSERC Celebrates Canada’s Young Entrepreneurial Researchers for Excellence in Innovation

 

October 15, 2012

Living Life to the Fullest

 

October 15, 2012

Sirona Biochem Announces Loan Offering

 

October 12, 2012

Canada Research Chair for Dr. Brian Kwon

 

October 12, 2012

Vancouver Stories of Innovation and Action Celebrated at CityStudio’s AHA!

 

October 12, 2012

iCo Therapeutics` Oral Amphotericin B Delivery System to be Presented at AAPS with Updated Patent Position

 

October 11, 2012

Sirona Biochem Names Neil Belenkie as Chief Executive Officer

 

October 11, 2012

Business growth with a difference

 

October 11, 2012

Boehringer Ingelheim congratulates Nobel Prize winner Prof. Brian Kobilka

 

October 11, 2012

ICORD research at American Congress of Rehabilitation Medicine

 

October 10, 2012

Allons CEO presenting at 2012 BIO Investor Forum and Updating Guidance

 

October 10, 2012

HIV-AIDS Testing Market to Explode to $4.4 Billion by 2016

 

October 10, 2012

EnWave’s 2nd Tier 1 Collaborator Initiates Market Evaluation Phase and Expands Target Product Testing Categories

 

October 10, 2012

Functional Technologies Closes Second Tranche of Private Placement

 

October 10, 2012

MedGenesis Announces New Grant for the Development of GDNF

 

October 10, 2012

Sauder announces its first FRED scholarship winner

 

October 10, 2012

Paralympic wheelchair athletes: struggles behind the gold

 

October 9, 2012

Maternal depression affects language development in babies

 

October 9, 2012

Qu Biologics is pleased to announce the appointment of Dr. Julia Levy to their Board of Directors

 

October 9, 2012

PharmaNet/i3 to Present Scientific Posters at the 2012 American Association of Pharmaceutical Scientists (AAPS)

 

October 9, 2012

Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker 14-3-3η as a Testing Service in the U.S.

 

October 5, 2012

Change in the Board of Managing Directors at Boehringer Ingelheim

 

October 5, 2012

UVic Recognized As One Of The World’s Top Universities

 

October 5, 2012

Allon Featured in Seeking Alpha: “A Little Known Biotech With a Big 2012 Event: Introducing Allon Therapeutics”

 

October 4, 2012

Genzyme Applauds Health Canada for Focusing on Patients with Rare Diseases

 

October 4, 2012

Health Minister Dr. Margaret MacDiarmid today announced a $48-million funding commitment to support the ongoing work of the Michael Smith Foundation for Health Research (MSFHR).

 

October 4, 2012

Dr. Brener joins the management team as Chief Business Development Officer

 

October 4, 2012

Rx&D applauds Health Canada for progress in Canadian policy on drugs for rare diseases

 

October 4, 2012

Functional Technologies Reports Increase in Non-Brokered Private Placement

 

October 4, 2012

Sirona Biochem to Present Scientific Poster at Canadian Diabetes Professional Conference

 

October 4, 2012

Jamil Hantash Joins PharmaNet/i3 As Director of Immunochemistry Operations

 

October 4, 2012

Vest helps man breathe easy (VIDEO)

 

October 3, 2012

$48M for health research in BC!

 

October 2, 2012

Genzyme Phase 3 Study of Oral Compound Eliglustat Tartrate for Gaucher Disease Meets Primary Endpoint

 

October 2, 2012

Neovasc Inc. Announces Lemaitre Vascular Will Accelerate Its Acquisition Of Rights To In-House Manufacture Of Xenosure Product

 

October 2, 2012

BCC unveils new career portal for Sauder alumni

 

October 2, 2012

Sauder professor co-chairs world’s largest consumer research conference

 

October 1, 2012

Heating and lighting upgrades at the BC Cancer Agency to increase patient comfort

 

October 1, 2012

Board of Trade celebrates Small Business Month in B.C.

 

September 27, 2012

New president arrives at BC Cancer Agency

 

September 27, 2012

ICORD research clinician receives top award!

 

September 27, 2012

QLT Announces Share Repurchase Program

 

September 27, 2012

ViewsIQ at NSH Booth #530

 

September 26, 2012

Wait time for inherited breast cancer testing cut dramatically with new technology

 

September 26, 2012

Lifebank Announces Changes to Board of Directors

 

September 26, 2012

Scientists find way to control sugars

 

September 26, 2012

PROOF Centre and MRM Proteomics Partner to Bring New Tests to Clinic

 

September 26, 2012

Functional Technologies Reports Increase in Non-Brokered Private Placement

 

September 26, 2012

CTV’s Coleen Christie will host Spinal Chord

 

September 26, 2012

JHRC Friday Seminar Series: “Bioprospecting novel natural products for potential anti-infective drugs”

 

September 26, 2012

Capital upgrades at BC Cancer Agency improve patient experience

 

September 25, 2012

Bone loss, leg swelling solutions on horizon

 

September 24, 2012

Perceptronix Announces Publication of Important Clinical Study Evaluating its Oral Cancer Detection Test

 

September 24, 2012

EnWave Receives Favorable PCT Review for powderREVâ„¢ III Recycling System

 

September 24, 2012

Merck Canada Working Hands-On To Advance Maternal Health As Part Of Community Action Day

 

September 24, 2012

Dr. Krassioukov inducted into Canadian Academy of Health Sciences

 

September 24, 2012

QLT Announces Sale Of Visudyne ® To Valeant Pharmaceuticals

 

September 24, 2012

Functional Technologies Reports Increase in Non-Brokered Private Placement

 

September 24, 2012

SORIN GROUP: 2012-2017 STRATEGIC PLAN

 

September 21, 2012

Cardiome Announces Appointment Of Jennifer Archibald As Chief Financial Officer

 

September 20, 2012

Broken hearts – VCH Research aims to reduce heart damage from cancer treatment

 

September 20, 2012

Functional Technologies Announces Letter of Commitment from Leading Global Yeast Producer for Initial Production and Supply of Acrylamide-Preventing Yeast

 

September 20, 2012

Premier opens Southern Medical Program’s Reichwald Health Sciences Centre

 

September 19, 2012

Tekmira Provides Periodic Update to Shareholders Regarding Litigation

 

September 18, 2012

The University of Saskatchewan awards Dr. Bruce McManus with the 2012 Alumni Achievement Award

 

September 18, 2012

Sorin Group Announces Ce Mark Approval Of Extended Indications And 2nd Generation Accessories For Percevaltm S

 

September 17, 2012

Functional Technologies Announces Internal Promotion of Chief Technology and Innovations Officer and Board Changes

 

September 17, 2012

Tommy Europe invites you to Bust a Move for Breast Cancer Research

 

September 17, 2012

Canadians Embrace Strong Intellectual Property Protection

 

September 17, 2012

Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation

 

September 17, 2012

SFU a top 10 research university

 

September 17, 2012

Prostate Cancer Awareness Week: Vancouver Prostate Centre takes revolutionary approach to drug discovery

 

September 14, 2012

Functional Technologies Launches New Selectively Bred Phyterra(tm) Hydrogen Sulphide (H2S) -Preventing Wine Yeasts in Ten Countries

 

September 14, 2012

Paralympic research clinic was a success

 

September 14, 2012

The impact of arthritis on mothers

 

September 13, 2012

MRM Proteomics, Agilent Technologies Sign Comarketing Agreement to Further Quantitative Proteomics Solutions

 

September 13, 2012

Functional Technologies Announces Launch of Hydrogen Sulphide-Preventing Wine Yeasts for Commercial Sale in Canada, Positive Data from Independent Wineries

 

September 13, 2012

FDA Approves Genzyme’s AUBAGIO ® (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis

 

September 13, 2012

Prostate cancer patients benefit from “drug holiday”

 

September 13, 2012

Sorin group receives SFDA approval and announces commercial launch of replyâ„¢ and espritâ„¢ families of pacemakers in China

 

September 13, 2012

Dr. Sawatzky to be honoured

 

September 12, 2012

Verisante Places Aura Beta Units For Safety, Verification Testing in B.C., Alberta and Ontario Clinics

 

September 12, 2012

Solegear Bioplastics to develop new bioplastic technology with the National Research Council of Canada

 

September 11, 2012

Indel Therapeutics Named Industry Partner for New Genomics Research Project

 

September 11, 2012

Collaborative maternity program results in fewer C-sections, shorter hospital stays: UBC/CFRI research

 

September 11, 2012

One man’s pancreatic cancer diagnosis sparks major initiative to change outcomes of the deadly disease

 

September 11, 2012

Verisante to Present at Rodman & Renshaw Annual Global Investment Conference

 

September 11, 2012

Allons CEO presenting at 2012 Rodman and Renshaw Global Conference

 

September 11, 2012

PROOF & IO Informatics work on web-based app to improve patient care

 

September 10, 2012

Verisante to Present at Rodman & Renshaw Annual Global Investment Conference

 

September 10, 2012

RepliCel to Present at Rodman and Renshaw Global Investment Conference

 

September 10, 2012

Funding for neglected global diseases research at UBC exceeds $20M

 

September 10, 2012

Cardiome Notes Updated Guidelines From European Society of Cardiology Now Include BRINAVESS(TM) For Infusion

 

September 10, 2012

Wax-it Histology Services Successfully Completes 2 GLP Studies

 

September 10, 2012

Karolinska Institutet and The Centre for Drug Research and Development (CDRD) Form International Collaborative Partnership

 

September 10, 2012

Combination of blood thinning drugs shown to be ineffective as stroke preventer

 

September 10, 2012

Boehringer Ingelheim implements flexible fully disposable up- and downstream manufacturing for biopharmaceuticals

 

September 6, 2012

Zymeworks Completes $11.0 Million Private Placement Financing to Advance Therapeutics Programs and Platform Technologies

 

September 6, 2012

Zymeworks Inc. to Receive Milestone Payment from Merck for Bi-specific Antibody Therapeutics Collaboration

 

September 6, 2012

UBC Pharmacy Alum Receives National Research Grant

 

September 6, 2012

EXCITING UPDATE FROM THE WORLD OF BC BIOTECHNOLOGY

 

September 6, 2012

2012 WBT Innovation Marketplace Presenters Announced

 

September 5, 2012

iCo Therapeutics to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference

 

September 5, 2012

iCo Therapeutics Announces Second Quarter 2012 Financial Results

 

September 5, 2012

Study seeks new insight into declining child heart health

 

September 5, 2012

VCH stroke researcher shows blood thinning drug to be ineffective as stroke preventer

 

September 5, 2012

Functional Technologies Announces GRAS Submission on Acrylamide Yeast has been Accepted by the US Food and Drug Administration

 

September 4, 2012

Sanofi to buy back CVRs for up to $152 mln

 

September 4, 2012

Phase III results: tiotropium* Respimat ® significantly reduces exacerbations in asthma patients still symptomatic despite ICS/LABA treatment

 

September 3, 2012

Sauder’s new leader: Dean Robert Helsley

 

August 30, 2012

Progesterone shown to be effective for severe hot flushes

 

August 29, 2012

Best Lawyers Names James Hatton, Q.C. as Vancouver’s 2013 Biotechnology Lawyer of the Year

 

August 27, 2012

Key results from new tiotropium studies in COPD and asthma to be presented at ERS 2012

 

August 27, 2012

Genzyme Provides Update on U.S. LEMTRADAâ„¢Filing

 

August 25, 2012

Annual Golf Classic Succeeds in Sindi’s Memory

 

August 24, 2012

Paralympic Boosting: Dr. Krassioukov weighs in

 

August 24, 2012

Sunbathing keeps these insects healthy – study

 

August 23, 2012

Canadian Researcher Works to Make Paralympic Games Safer

 

August 22, 2012

Researchers identify markers that predict progression of oral lesions to cancer

 

August 21, 2012

Insception Mails Offer to Lifebank Shareholders

 

August 20, 2012

Genome BC Geneskool Camp to turn local students into budding scientists

 

August 17, 2012

Response Biomedical Corporation Announces: Share Consolidation

 

August 17, 2012

Ocular Pharmacokinetic Research Challenges

 

August 15, 2012

Government Of Canada Invests In A Stronger Health Care System

 

August 14, 2012

SFU health-related research nets new financial awards

 

August 10, 2012

Response Biomedical Corporation Announces Appointment of W.J. (Bill) Adams as CFO & Corporate Secretary and Resignation of Richard A. Canote as CFO

August 10, 2012

BCIC names new President and CEO

 

August 9, 2012

Functional Technologies Closes First Tranche of Private Placement

 

August 9, 2012

Solegear Bioplastics Completes Series A Financing Led by Yaletown Venture Partners

 

August 9, 2012

Neovasc Inc. reports financial results for second quarter of 2012

 

August 7, 2012

Allon Therapeutics releases Q2 operating results and provides corporate update

 

August 7, 2012

OncoGenex Announces Initiation of the Phase 3 “AFFINITY” Trial for Patients with Advanced Prostate Cancer

 

August 7, 2012

Response Biomedical Corporation Announces: Second Quarter 2012 Financial Results

 

August 3, 2012

Response Biomedical Corp. Schedules Second Quarter 2012 Earnings Release and Announces Conference Call

 

August 2, 2012

QLT Announces Second Quarter 2012 Results

 

August 2, 2012

EnWave Signs Market Development Agreement with Milne Fruit Products Inc.

 

August 2, 2012

OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427

 

July 30, 2012

Response Biomedical Corporation Announces Appointment of Dr. Jonathan Wang as Director

 

July 26, 2012

SFU duo’s protein discovery links to cancer research

 

July 26, 2012

Response Biomedical Corp. Announces: New Hire Mr. Tim Shannon as Senior Vice President, World Wide Sales & Marketing

 

July 26, 2012

Premiers’ Prescription Good First Step for Canadian Health Care System

 

July 25, 2012

Biolux Research announces appointment of Dr. Chung How Kau to Clinical and Scientific Advisory Board

 

July 25, 2012

Vancouver scientists discover subgroups in childhood brain cancer

 

July 25, 2012

OncoGenex to Webcast Discussion of Second Quarter 2012 Financial Results on Thursday, August 2, 2012

 

July 25, 2012

Response Biomedical Corporation Announces Appointment of Jeffrey L. Purvin as Director & CEO and Resignation of Peter Thompson as Interim CEO

 

July 25, 2012

Verisante Technology, Inc. Takes Delivery of Aura Devices from StarFish Medical Inc.

 

July 24, 2012

$1.4 M study on using plants to recover rare metals from mine waste: UBC research

 

July 23, 2012

Study offers mid-island residents an opportunity to help future generations

 

July 23, 2012

FDA Grants CLIA Waiver to bioLytical Laboratories INSTâ„¢ Rapid HIV Test Innovative Screening Assay Detects HIV Antibodies in 60 Seconds or Less

 

July 20, 2012

Severe flu increases risk of Parkinson’s

 

July 19, 2012

Research funding targets bone health

 

July 19, 2012

The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program

 

July 18, 2012

Vancouver Coastal Health & Providence Health Care aim to change the course of “HIVstory”

 

July 18, 2012

Widely prescribed MS treatment may not slow progression of disease:

 

July 18, 2012

Dr. Bruce McManus awarded Aubrey J. Tingle Prize

 

July 18, 2012

2012 scholars announced

 

July 18, 2012

Resource puts research within students’ reach

 

July 18, 2012

Single-cell parasites co-opt “ready-made” genes from host

 

July 17, 2012

Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation

 

July 17, 2012

Response Biomedical Corporation receives funding from the Government of Canada to support RAMP ® Point-of-Care platform

 

July 16, 2012

iCo Therapeutics Closes $2.55 Million Financing

 

July 16, 2012

Allon Presents Baseline Data from PSP Clinical Trial to Alzheimer’s Conference

 

July 16, 2012

Tekmira’s LNP Technology Enables Alnylam’s Positive ALN-TTR02 Clinical Data

 

July 13, 2012

The Marker : PROOF Centre of Excellence Quarterly eBulletin July 2012 Volume 01

 

July 12, 2012

BC CRIN Launches Certification Program to Boost BC’s Competitive Edge in Clinical Research

 

July 12, 2012

BIOMEDICAL ENGINEERING DEGREE FIRST IN WESTERN CANADA

 

July 10, 2012

2012 The Michael Smith Foundation for Health Research Scholar Awards an investment in the health of British Columbians

 

July 10, 2012

OncoGenex Announces Clinical Development Plans for Custirsen in Non-Small Cell Lung Cancer

 

July 5, 2012

iCo Therapeutics Announces Overnight Marketed Equity Offering

 

July 5, 2012

iCo Therapeutics to Raise $2.55 Million

 

July 4, 2012

SFU mentors winning high school science researchers

 

July 3, 2012

Cardiome Announces Management Change

 

July 3, 2012

Functional Technologies Appoints International Food Industry Executive to Advisory Board

 

July 3, 2012

iCo Therapeutics Featured in JDRF’s Top Research Highlights Publication

 

July 3, 2012

EnWave Closes Final Tranche of Private Placement

 

June 29, 2012

BC Cancer Foundation raises a record $50.4 million: Announced at 77th Annual General Meeting with introduction of new board directors

 

June 29, 2012

Sirona Biochem Releases Quarterly Financial Results

 

June 28, 2012

Lungpacer receives tech industry award

 

June 27, 2012

Sirona Biochem Retains Healthcare Investment Banking Firm Bloom Burton

 

June 27, 2012

Parkinson’s disease gene identified with help of Mennonite family: UBC-VCH research

 

June 27, 2012

Stem cells can beat back diabetes: UBC research

 

June 26, 2012

RepliCel’s Chief Scientific Officer Updates European Hair Research Society on RepliCel’s TS001-2009 First-in-man Clinical Trial

 

June 26, 2012

NSERC awards UBC $4.9 million to train young researchers

 

June 26, 2012

EnWave Closes First Tranche of Private Placement

 

June 25, 2012

New funding for diverse and innovative research projects

 

June 21, 2012

Allon CEO updates Bloom Burton & Co. Healthcare Investor Conference

 

June 21, 2012

Multiple sclerosis patients have lower risk of cancer: UBC-VCH research

 

June 20, 2012

Sirona Biochem Announces Primate Results for SGLT Inhibitor for Type 2 Diabetes

 

June 19, 2012

British Columbia Technology Report Card 2012

 

June 19, 2012

Response Biomedical Corporation Announces Results of Annual General Meeting

 

June 19, 2012

BC Provincial Government Announces $29 million in Renewed Support for CDRD

 

June 15, 2012

EnWave Announces Upsizing of Previously Announced Private Placement

 

June 15, 2012

2012 Technology Impact Award Winners Announced: BC Companies and Individuals Making Their Mark Globally

 

June 15, 2012

New BIOTECanada President and CEO

 

June 14, 2012

Protein Measured by a Blood Test Marks Joint Erosions in Arthritis

 

June 14, 2012

EnWave Signs Letter of Intent to Acquire 75.1% of Hans Binder Maschinenbau GmbH

 

June 14, 2012

Allon Therapeutics shareholders approve $10-million private placement

 

June 13, 2012

Electronic Recycling Regulation in British Columbia Now Applies to Medical Devices

 

June 11, 2012

RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders

 

June 10, 2012

SFU researchers contribute to study on HIV control

 

June 8, 2012

EnWave Signs Commercial Royalty-Bearing License with Tier 1 Partner to Initiate Broader Market Evaluation

 

June 6, 2012

Loss of biodiversity a growing threat to human life: UBC, University of Michigan Research

 

June 6, 2012

Verisante Technology, Inc. Exhibits at Leading Global and Canadian Radiation Technologist Events

 

June 6, 2012

Pyng Medical Corp. Extends Previously Announced $500,000 Non-Brokered Private Placement

 

June 5, 2012

Biolux Research Hosts Second Annual Light Accelerated Orthodontics and Bone Regeneration Clinical And Scientific Conference

 

June 5, 2012

The Centre for Drug Research and Development (CDRD) and CDRD Ventures Inc. (CVI) Announce Transition of Management to Lead Organizations to Next Stage of Success

 

June 5, 2012

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

 

June 5, 2012

UBC recognizes brain and heart researchers with $50,000 prizes

 

May 31, 2012

iCo Therapeutics receives funding from the Government of Canada for the pre-clinical and clinical development of its Oral Amphotericin B Delivery System for the treatment of HIV/AIDS

 

May 30, 2012

Allon CEO updates BioFinance Conference on pivotal trial progress and DSMB recommendation

 

May 30, 2012

iCo Therapeutics Announces First Quarter 2012 Financial Results

 

May 29, 2012

Neovasc Inc. Reports Financial Results for First Quarter of 2012

 

May 29, 2012

CDRD and CDRD Ventures Inc. Enter into a Collaboration with GSK to Advance the Development and Commercialization of Canadian Health Research

 

May 25, 2012

Zymeworks Receives Inaugural Biotech Rising Star Award at the 14th Annual C21 BioVenturesâ„¢ Conference

 

May 24, 2012

Sirona Biochem to Present at BioFinance Conference

 

May 24, 2012

QLT Highlights Strategic Initiatives to Enhance Shareholder Value: Board to Propose $75 Million to $100 Million Dutch Auction Tender Offer

 

May 24, 2012

Medical Device Development Firm, StarFish Medical, Welcomes Bay Area Medical Device Veteran, Ben Clawson, to its Advisory Board

 

May 23, 2012

QLT Announces Notification of Legal Proxy Action in Advance of Annual Meeting of Stockholders

 

May 18, 2012

BCCRIN Launches Innovative Clinical Trial Surveys

 

May 14, 2012

New Allon research presented at leading scientific symposium

 

May 9, 2012

Abbott’s New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada

 

May 8, 2012

Verisante Technology, Inc. Announces Completion of Beta Units

 

May 8, 2012

Allon Therapeutics releases first quarter 2012 operating results

 

May 3, 2012

QLT Announces First Quarter 2012 Results

 

May 3, 2012

OncoGenex Pharmaceuticals, Inc. Reports Financial Results and Reviews Clinical Development Highlights for First Quarter of 2012

 

May 2, 2012

Allon Therapeutics announces completion of $10 million private placement

 

May 2, 2012

RepliCel Releases Positive Results from the Interim Analysis of Data from its First-in-man TS001-2009 Clinical Trial

 

April 27, 2012

VWR International, LLC Signs Agreement to Acquire basan Germany GmbH

 

April 26, 2012

UBC Dentistry gains $1M to enhance patient-based research and knowledge transfer

 

April 25, 2012

Genome BC Geneskool workshops turn local students into budding scientists

 

April 25, 2012

OncoGenex to Webcast Discussion of First Quarter 2012 Financial Results on Thursday, May 3, 2012

 

April 23, 2012

Sanofi Pasteur invests $1.3 million and curbs its CO2 emissions by more than 2,300 tonnes per year

 

April 23, 2012

Preventing dementia: new research by VCH and UBC shows the trajectory of cognitive decline can be altered in seniors at risk for dementia

 

April 19, 2012

Media Advisory: QLT to Report First Quarter Financial Results on May 3, 2012

 

April 19, 2012

Study finds cancer-fighting goodness in cholesterol

 

April 17, 2012

EnWave Announces Milne Fruit Products Inc. Begins Commercial Production

 

April 16, 2012

Allon Therapeutics announces private placement

 

April 16, 2012

Genome BC: Time to Breathe a Sigh of Relief

 

April 16, 2012

QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer

 

April 13, 2012

iCo Therapeutics Announces Year End 2011 Financial Results

 

April 13, 2012

Response Biomedical Corporation Announces: Agreement with Jeffrey L. Purvin to become Chief Executive Officer

 

April 11, 2012

Pyng Medical Corp. Announces Election of Directors and Officers and Approval of Stock Option Plan at 2012 Annual General Meeting

 

April 10, 2012

UBC president helps identify key steps to respond to growing Asia Pacific research strengths

 

April 9, 2012

Analyst Note – Verisante: Aura Data Published. Operations On-Track

 

April 5, 2012

Verisante Chosen as “Pick of the Street” in the Technology and Life Sciences Sector

 

April 4, 2012

Scientists uncover multiple faces of deadly breast cancer

 

April 4, 2012

Darwinian evolution in the deadliest of breast cancers

 

April 4, 2012

The plight of orphan diseases

 

April 3, 2012

VWR International, LLC Acquires VITRUM PRAHA S.R.O. and VITRUM ROZNOV S.R.O. in the Czech Republic

 

April 2, 2012

Protox Therapeutics Changes Name to Sophiris Bio

 

April 2, 2012

SFU HIV/AIDS vaccine research gets financial boost

 

April 2, 2012

SFU HIV AIDS vaccine research gets financial boost

 

April 2, 2012

Ultra-Fast Laser Pulses Shed Light on Elusive Superconducting Mechanism: UBC Research

 

March 28, 2012

Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs

 

March 27, 2012

iCo Therapeutics CEO to Present at Retinal Physician Symposium 2012

 

March 27, 2012

Cardiome to Release Fourth Quarter and Fiscal 2011 Results

 

March 23, 2012

OncoGenex Pharmaceuticals, Inc. Announces Full Exercise of Overallotment Option by Underwriters

 

March 22, 2012

Better water for better health

 

March 21, 2012

Protox Therapeutics : Protox Reports Fourth Quarter and Full Year 2011 Financial Results and Achievements

 

March 21, 2012

Tekmira Provides Update on Licensed Product Candidate, Marqibo

 

March 20, 2012

Verisante Aura Clinical Study Results to be Published in ‘Cancer Research’

 

March 19, 2012

Cardiome Provides Update on Merck’s Development Plans for Vernakalant Oral

 

March 19, 2012

QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy

 

March 19, 2012

UBC animal research vindicated by Canadian Council on Animal Care

 

March 16, 2012

OncoGenex Pharmaceuticals, Inc. Prices $50 Million Public Offering

 

March 16, 2012

Exposure to antibiotics linked to severity of allergic asthma: UBC research

 

March 14, 2012

Sirona Biochem Announces Addition of Dr. Brett Premack as Scientific Consultant

 

March 14, 2012

Verisante Technology, Inc. Announces Exclusive Distribution Agreement with Clarion Medical Technologies Inc.

 

March 13, 2012

UBC gains nine more Canada Research Chairs valued at $10 million

 

March 13, 2012

Biolux Research Announces srart of two additional clinical trials for light-accelerated orthodontics

 

March 12, 2012

Allon advances Parkinson’s disease program

 

March 12, 2012

Sirona Biochem Inducer Produces More Protein than Commercial Leader in Study

 

March 12, 2012

New Research Chairs Tlackle Molecular Basis Of Disease

 

March 9, 2012

iCo Therapeutics Grants Options to Director and Consultant

 

March 5, 2012

Allon broadens intellectual property with new patent

 

March 1, 2012

QLT Announces Positive Preliminary Results From Phase 1b Trial of QLT091001 in Subjects With Retinitis Pigmentosa Due to RPE65 and LRAT Mutations

 

March 1, 2012

Tekmira Expands Product Pipeline With RNAi Therapeutic for the Treatment of Alcohol Dependence

 

February 29, 2012

New publication describes Allon’s davunetide as the most advanced global drug candidate for PSP

 

February 29, 2012

Sirona Biochem Announces Diabetes Preclinical Results in Chronic Study

 

February 28, 2012

Genome BC to provide strategic funding for therapeutic HPV vaccine

 

February 20, 2012

Fight Against Neglected Global Diseases Moves Another Step Forward Through a Partnership Between CDRD and NGDI-UBC

 

February 17, 2012

AAAS-SFU research: Searching for gold in cancer treatment

 

February 16, 2012

Boreal Genomics Announces Early Access Program for OnTargetâ„¢ Allele Enrichment System

 

February 16, 2012

AAAS-SFU research: Linking human evolution and climate change

 

February 15, 2012

New drugs show promise for preventing “absence seizures” in children: UBC research

 

February 15, 2012

Verisante Technology, Inc. Named Top Technology and Life Sciences Company on the TSX Venture Top 50 2012 Ranking

 

February 15, 2012

EnWave Named to the TSX Venture Top 50 for Third Consecutive Year

 

February 14, 2012

Sirona Biochem Announces Results in Key Study for Biological Inducer

 

February 14, 2012

AAAS-SFU research: Vancouver, unique space for innovation

 

February 14, 2012

Sirona Biochem Appoints Three Chemistry Experts to Subsidiary Scientific Advisory Board

 

February 13, 2012

Allons Data Safety Monitoring Board recommends continuation of pivotal clinical trial

 

February 10, 2012

SFU primes science high school students at AAAS

 

February 8, 2012

Tekmira Announces Initiation of TKM-Ebola Phase 1 Clinical Trial

 

February 6, 2012

Neovasc Inc. Issues Incentive Options to Management

 

February 3, 2012

MSFHR partners on community-based primary health care team grant

 

February 1, 2012

IMMUNE Pharmaceuticals Granted US $1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel

 

January 31, 2012

New hires bolster core team needed to open cancer centre

 

January 30, 2012

Understanding — and beating — childhood brain cancer

 

January 27, 2012

SFU scientists aim to wow non-scientists at AAAS

 

January 24, 2012

Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors

 

January 20, 2012

Biolux Research Announces Allowance of Key Light Therapy Patent and Filing of New Light Accelerated Orthodontics Patent Applications

 

January 19, 2012

OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium

 

January 18, 2012

UBC researchers to sequence Chardonnay genome

 

January 17, 2012

iCo Therapeutics Retains Crescendo Communications

 

January 16, 2012

EnWave Announces Successful quantaREVâ„¢ Scale-up

 

January 10, 2012

MedGenesis Therapeutix raises $5.0 million in equity financing to support the Phase II development of GDNF in Parkinson’s Disease

 

January 9, 2012

Xenon to Collaborate with Genentech on Discovery of Novel Targeted Pain Therapeutics

 

January 5, 2012

Zymeworks Announces the Formation of its Therapeutics Advisory Team, and Appointment of VP, Preclinical R&D to Advance its Strategic Therapeutics Initiative

 

January 5, 2012

UBC researchers identify potential new therapy approach for Hepatitis C that could benefit 170 million people affected worldwide

 

January 3, 2012

From the Forest to the Highway: How close are we to advanced biofuels?

 

January 1, 2012

Immune cell discovery could lead to more efficient vaccines

 

January 1, 2012

EnWave gets agri-food award for innovation

 

January 1, 2012

Verisante Aura Clinical Study Data Analysis Presented at SPIE

 

January 1, 2012

HIV AIDS vaccine research gets financial boost